CIK 2026172
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 83.08% | 74 |
| Unclassified | 12.68% | 9 |
| Life Sciences Tools & Services | 3.98% | 2 |
| Health Care Providers & Services | 0.25% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | BRIDGEBIO PHARMA INC | Unclassified | 7.67% | |
| 2 | VKTX | Viking Therapeutics, Inc. | Health Care | 7.06% |
| 3 | UTHR | UNITED THERAPEUTICS Corp | Health Care | 6.69% |
| 4 | JNJ | JOHNSON & JOHNSON | Health Care | 5.43% |
| 5 | COGT | Cogent Biosciences, Inc. | Health Care | 5.13% |
| 6 | JAZZ | Jazz Pharmaceuticals plc | Health Care | 4.27% |
| 7 | TERNS PHARMACEUTICALS INC | Unclassified | 3.96% | |
| 8 | BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | 3.46% |
| 9 | ABVX | Abivax S.A. | Health Care | 3.39% |
| 10 | RVMD | Revolution Medicines, Inc. | Health Care | 3.25% |
77/86 names classified · sector 87.3% of weight · industry 87.3% · mkt cap 82.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 87.3% of the book is sector-classified (unclassified names shown, never dropped).
Only 30% of book weight classified — the grid is NOT representative of the whole book.
Classified: 29.6% of book weight (13/85 names) · unclassified 70.4%: , VKTX, COGT, JAZZ, ABVX, RVMD, KOD, BBIO, IMCR, RCUS +62 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | BRIDGEBIO PHARMA INC | 250,000 | $19M | 7.7% | NEW |
| 2 | VKTXVIKING THERAPEUTICS INC | 525,181 | $17M | 7.1% | ADD 56% |
| 3 | UTHRUnited Therapeutics Corp. | 27,303 | $16M | 6.7% | ADD 173% |
| 4 | JNJJOHNSON & JOHNSON | 53,771 | $13M | 5.4% | TRIM −19% |
| 5 | COGTCOGENT BIOSCIENCES INC | 322,764 | $12M | 5.1% | ADD 145% |
| 6 | JAZZJAZZ PHARMACEUTICALS PLC | 54,755 | $10M | 4.3% | NEW |
| 7 | TERNS PHARMACEUTICALS INC | 181,752 | $10M | 4.0% | TRIM −47% |
| 8 | BMRNBIOMARIN PHARMACEUTICAL INC | 148,229 | $8M | 3.5% | HOLD |
| 9 | ABVXABIVAX SA | 75,944 | $8M | 3.4% | HOLD |
| 10 | RVMDREVOLUTION MEDICINES INC | 80,872 | $8M | 3.2% | ADD 118% |
| 11 | KODKODIAK SCIENCES INC | 192,962 | $7M | 3.0% | NEW |
| 12 | INCYINCYTE CORP | 78,029 | $7M | 3.0% | NEW |
| 13 | TGTXTG THERAPEUTICS INC | 206,928 | $7M | 2.8% | ADD 68% |
| 14 | BBIOBRIDGEBIO PHARMA INC | 85,311 | $6M | 2.6% | ADD 22% |
| 15 | IMCRIMMUNOCORE HLDGS PLC | 193,189 | $6M | 2.4% | ADD 175% |
| 16 | LLYELI LILLY & CO | 6,000 | $6M | 2.3% | ADD 200% |
| 17 | ABBVABBVIE INC | 24,058 | $5M | 2.2% | NEW |
| 18 | RCUSARCUS BIOSCIENCES INC | 238,142 | $5M | 2.1% | NEW |
| 19 | CRBPCORBUS PHARMACEUTICALS HLDGS | 439,957 | $4M | 1.7% | NEW |
| 20 | CRVSCORVUS PHARMACEUTICALS INC | 244,811 | $4M | 1.5% | NEW |
| 21 | ZYMEZYMEWORKS INC | 142,132 | $4M | 1.5% | NEW |
| 22 | GPCRSTRUCTURE THERAPEUTICS INC | 72,234 | $3M | 1.4% | NEW |
| 23 | GLUEMONTE ROSA THERAPEUTICS INC | 187,307 | $3M | 1.3% | ADD 201% |
| 24 | TENXTENAX THERAPEUTICS INC | 179,738 | $3M | 1.2% | TRIM −26% |
| 25 | HRMYHARMONY BIOSCIENCES HLDGS IN | 92,864 | $3M | 1.1% | ADD 1138% |
| 26 | CAPRCAPRICOR THERAPEUTICS INC | 78,851 | $2M | 1.0% | TRIM −50% |
| 27 | EYPTEYEPOINT INC | 178,545 | $2M | 1.0% | NEW |
| 28 | BCYCBICYCLE THERAPEUTICS PLC | 476,424 | $2M | 0.9% | NEW |
| 29 | INDVINDIVIOR PHARMACEUTICALS INC COM | 71,376 | $2M | 0.9% | NEW |
| 30 | CLYMCLIMB BIO INC | 286,126 | $2M | 0.8% | NEW |
| 31 | IVAINVENTIVA SA | 352,399 | $2M | 0.8% | ADD 5% |
| 32 | STTKSHATTUCK LABS INC | 293,664 | $2M | 0.8% | NEW |
| 33 | TARSTARSUS PHARMACEUTICALS INC | 25,942 | $2M | 0.8% | NEW |
| 34 | ALKSALKERMES PLC | 50,000 | $2M | 0.7% | NEW |
| 35 | MGNXMACROGENICS INC | 600,000 | $2M | 0.7% | NEW |
| 36 | VRTXVERTEX PHARMACEUTICALS INC | 3,840 | $2M | 0.7% | TRIM −62% |
| 37 | VYGRVOYAGER THERAPEUTICS INC | 423,642 | $2M | 0.7% | NEW |
| 38 | PCVXVAXCYTE INC | 25,071 | $1M | 0.6% | ADD 9% |
| 39 | RLMDRELMADA THERAPEUTICS INC | 200,842 | $1M | 0.6% | TRIM −48% |
| 40 | BIOABIOAGE LABS INC | 60,000 | $1M | 0.4% | TRIM −78% |
| 41 | INOINOVIO PHARMACEUTICALS INC | 562,665 | $979,037 | 0.4% | ADD 5% |
| 42 | AYTUAYTU BIOPHARMA INC | 353,077 | $963,900 | 0.4% | ADD 15% |
| 43 | EQEQUILLIUM INC | 433,844 | $867,688 | 0.4% | ADD 25% |
| 44 | DNTHDIANTHUS THERAPEUTICS INC | 10,000 | $839,200 | 0.3% | NEW |
| 45 | PHVSPHARVARIS N V | 29,321 | $828,318 | 0.3% | NEW |
| 46 | ENTAENANTA PHARMACEUTICALS INC | 64,952 | $820,344 | 0.3% | HOLD |
| 47 | REPLREPLIMUNE GROUP INC | 100,660 | $770,049 | 0.3% | TRIM −56% |
| 48 | XERSXERIS BIOPHARMA HOLDINGS INC | 132,746 | $769,927 | 0.3% | TRIM −22% |
| 49 | LRMRLARIMAR THERAPEUTICS INC | 166,637 | $749,867 | 0.3% | NEW |
| 50 | ANNXANNEXON INC | 132,916 | $736,355 | 0.3% | TRIM −62% |
| 51 | RAREULTRAGENYX PHARMACEUTICAL IN | 35,144 | $736,267 | 0.3% | NEW |
| 52 | MLYSMINERALYS THERAPEUTICS INC | 26,347 | $713,740 | 0.3% | ADD 5% |
| 53 | UNCYUNICYCIVE THERAPEUTICS INC | 106,083 | $698,026 | 0.3% | NEW |
| 54 | SPRBSPRUCE BIOSCIENCES INC | 10,000 | $653,500 | 0.3% | NEW |
| 55 | PHATPHATHOM PHARMACEUTICALS INC | 54,650 | $607,162 | 0.3% | NEW |
| 56 | CELCCELCUITY INC | 5,314 | $606,540 | 0.3% | NEW |
| 57 | CNTBCONNECT BIOPHARMA HLDGS LTD | 200,690 | $525,808 | 0.2% | NEW |
| 58 | NVONOVO-NORDISK A S | 14,577 | $520,736 | 0.2% | NEW |
| 59 | PTHSPELTHOS THERAPEUTICS INC | 24,773 | $520,481 | 0.2% | HOLD |
| 60 | QUREUNIQURE NV | 31,200 | $510,120 | 0.2% | TRIM −31% |
| 61 | MNKDMANNKIND CORP | 186,603 | $457,177 | 0.2% | TRIM −38% |
| 62 | MAZEMAZE THERAPEUTICS INC | 15,000 | $447,750 | 0.2% | NEW |
| 63 | URGNUROGEN PHARMA LTD | 23,155 | $416,327 | 0.2% | ADD 6% |
| 64 | CORTCORCEPT THERAPEUTICS INC | 10,000 | $403,100 | 0.2% | TRIM −90% |
| 65 | LPCNLIPOCINE INC NEW | 50,000 | $399,500 | 0.2% | TRIM −81% |
| 66 | FHTXFOGHORN THERAPEUTICS INC | 79,944 | $382,132 | 0.2% | ADD 161% |
| 67 | GHRSGH RESEARCH PLC | 26,836 | $377,314 | 0.2% | NEW |
| 68 | OCGNOCUGEN INC | 200,000 | $362,000 | 0.1% | NEW |
| 69 | PRQRPROQR THRAPEUTICS N V | 180,083 | $291,734 | 0.1% | ADD 7% |
| 70 | EPRXEupraxia Pharmaceuticals Inc | 40,000 | $289,600 | 0.1% | NEW |
| 71 | PEPGPEPGEN INC | 150,925 | $267,137 | 0.1% | NEW |
| 72 | TRVITREVI THERAPEUTICS INC | 21,663 | $258,440 | 0.1% | TRIM −78% |
| 73 | PGENPRECIGEN INC | 55,293 | $213,984 | 0.1% | NEW |
| 74 | UPBUPSTREAM BIO INC | 21,609 | $194,481 | 0.1% | ADD 5% |
| 75 | CMPSCOMPASS PATHWAYS PLC | 31,885 | $176,324 | 0.1% | NEW |
| 76 | PASGPASSAGE BIO INC | 19,530 | $153,311 | 0.1% | NEW |
| 77 | TLPHTALPHERA INC | 153,563 | $114,696 | 0.0% | ADD 12% |
| 78 | RCKTROCKET PHARMACEUTICALS INC | 30,579 | $109,473 | 0.0% | NEW |
| 79 | MNPRMONOPAR THERAPEUTICS INC | 1,630 | $89,308 | 0.0% | NEW |
| 80 | VTGNVISTAGEN THERAPEUTICS INC | 105,428 | $60,252 | 0.0% | ADD 5% |
| 81 | RNAATRIUM THERAPEUTICS INC | 2,512 | $33,585 | 0.0% | NEW |
| 82 | CUECUE BIOPHARMA INC | 131,997 | $30,346 | 0.0% | NEW |
| 83 | ENTXENTERA BIO LTD | 23,260 | $25,819 | 0.0% | NEW |
| 84 | PRTCYPURETECH HEALTH PLC | 7,924 | $11,327 | 0.0% | ADD 6% |
| 85 | ELVNENLIVEN THERAPEUTICS INC | 245 | $9,604 | 0.0% | NEW |
| 86 | SEPNSEPTERNA INC | 202 | $4,854 | 0.0% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| BRIDGEBIO PHARMA INC | — | — | — | — | — | 250K | $19M |
| VKTXVIKING THERAPEUTICS INC | — | 104K | 197K | 194K | 337K | 525K | $17M |
| UTHRUnited Therapeutics Corp. | — | — | — | — | 10K | 27K | $16M |
| JNJJOHNSON & JOHNSON | — | — | — | — | 66K | 54K | $13M |
| COGTCOGENT BIOSCIENCES INC | 90K | 392K | 392K | 98K | 132K | 323K | $12M |
| JAZZJAZZ PHARMACEUTICALS PLC | 15K | 87K | 104K | 23K | — | 55K | $10M |
| TERNS PHARMACEUTICALS INC | 50K | 56K | 260K | 323K | 346K | 182K | $10M |
| BMRNBIOMARIN PHARMACEUTICAL INC | — | 53K | 193K | 213K | 146K | 148K | $8M |
| ABVXABIVAX SA | — | — | — | 42K | 76K | 76K | $8M |
| RVMDREVOLUTION MEDICINES INC | — | — | 79K | 59K | 37K | 81K | $8M |
| KODKODIAK SCIENCES INC | — | — | — | — | — | 193K | $7M |
| INCYINCYTE CORP | — | — | — | — | — | 78K | $7M |
| TGTXTG THERAPEUTICS INC | 48K | 208K | 371K | 61K | 123K | 207K | $7M |
| BBIOBRIDGEBIO PHARMA INC | — | — | — | — | 70K | 85K | $6M |
| IMCRIMMUNOCORE HLDGS PLC | — | 97K | 104K | 124K | 70K | 193K | $6M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
